Pharmocann Global Ltd announced a private placement of 111,100 common shares at a price of ILS 1.40 per share for gross proceeds of ILS 155,540 on April 16, 2024. The transaction included participation from new investor Simcha Yaakovovitz. The transaction has been approved by the board of directors of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
240 ILa | 0.00% |
|
-20.00% | +71.31% |
04-16 | Pharmocann Global Ltd announced that it has received ILS 0.15554 million in funding | CI |
03-31 | Pharmocann Global Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+71.31% | 1.65M | |
+23.46% | 249M | |
0.00% | 207M | |
+25.58% | 164M | |
+300.00% | 121M | |
+30.43% | 118M | |
-42.86% | 96.91M | |
+63.70% | 92.76M | |
-56.87% | 91.11M | |
0.00% | 87.15M |
- Stock Market
- Equities
- PMCN-M Stock
- News Pharmocann Global Ltd
- Pharmocann Global Ltd announced that it has received ILS 0.15554 million in funding